Lymphedema after Radical Mastectomy for Breast Cancer in Chinese Women: A 2 Year Follow-up Study of Incidence and Risk Factors
F. Liu,Y. Xie,Y. Hu,X. Liu,P. Shen,Y. Q. Zhu,Y. Tian,G. Jiang,X. Zhu
DOI: https://doi.org/10.1016/j.ijrobp.2015.07.550
2015-01-01
Abstract:As cancer treatments evolve, breast cancer mortality rates have significant declined. It is important to preventing and managing morbidity resulting from treatment effects in order to maximize the quality of life of breast cancer survivors. Breast cancer-related lymphedema (BCRL) is one of the most distressing long-term consequences of breast cancer treatment. However, the reported incidence of BCRL varies greatly and it is insufficient about the data on the specific time and the time course of lymphedema. This study aimed to describe the incidence trend with time, degree, and risk factors of lymphedema in breast cancer survivors. We conducted a 2-year prospective study of 157 women who had surgical treatment in the Second Affiliated Hospital of Soochow University from Jan. 1, 2012 to Dec. 31, 2012. Limb volume and symptom assessment data were measured pre-treatment and at month 1, 3, 6, 12, 18, 24 after surgery by circumferences and questionnaires. Definition of BCRL was an absolute change of 2cm or more in arm circumference compared to pre-operative measurements of the same arm by clinical assessment, the questionnaire was based loosely on the telephone questionnaire to characterize lymphedema of Norman. Analysis of risk factors for the development of BCRL was performed finally. Univariate analysis was performed by using Chi-Square test, and multivariable analysis was performed by using binary logistic regression. A total of 141 patients were available for evaluation. The median age was 51 years (range, 24–81). The incidences of BCRL by self-reported were 4.3%, 7.8%, 12.8%, 22.7%, 27.7% and 30.5% at the month 1, 3, 6, 12, 18, 24 after surgery. The rates measured using arm circumference were 2.8%, 6.4%, 11.3%, 21.3%, 25.5%, and 27.7% changing over time and slightly lower than those by questionnaire. In addition, among the 39 (27.7% of 141) affected women following the results of clinical assessment, 71.8% (28) were reported mild lymphedema, 28.2% reported moderate/severe lymphedema. Radical mastectomy (RM, 36.0% vs. 8.3%, p<0.05), axillary lymph node dissection (ALND, 35.9% vs. 12.8%, p<0.05), radiation therapy (51.1% vs. 16.0%, p<0.05) were independent risk factors for BCRL. Body mass index (BMI), age, hypertension, the numbers of lymph nodes removed, receipt of chemotherapy and/or hormonal therapy had no significant effect on development of BCRL in this study. BCRL is common complication for breast cancer patients but mostly mild. It can be diagnosed just 1 month post-surgery and the cumulative incidence of BCRL seems to increase with time up to 2 years from surgery, especially in first year, it increases faster. RM, ALND, and radiation therapy were independent risk factors in development of BCRL.